GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BDH Industries Ltd (BOM:524828) » Definitions » Capex-to-Revenue

BDH Industries (BOM:524828) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is BDH Industries Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

BDH Industries's Capital Expenditure for the three months ended in Mar. 2024 was ₹0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹271.08 Mil.

Hence, BDH Industries's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


BDH Industries Capex-to-Revenue Historical Data

The historical data trend for BDH Industries's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BDH Industries Capex-to-Revenue Chart

BDH Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.02

BDH Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BDH Industries's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, BDH Industries's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BDH Industries's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BDH Industries's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where BDH Industries's Capex-to-Revenue falls into.



BDH Industries Capex-to-Revenue Calculation

BDH Industries's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-18.934) / 858.31
=0.02

BDH Industries's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 271.082
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BDH Industries  (BOM:524828) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


BDH Industries Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of BDH Industries's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BDH Industries (BOM:524828) Business Description

Traded in Other Exchanges
N/A
Address
Nair Baug, Akurli Road, Kandivli (East), Mumbai, MH, IND, 400101
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The Company has one reportable segment which is pharmaceuticals. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others. It manufactures Sildenafil Citrate Tablets, Bulk Drugs and Others.

BDH Industries (BOM:524828) Headlines

No Headlines